ENDONOVO THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2019 | $7.5M | $-11.6M | $58.5K |
| Jun 2019 | $7.5M | $-16.2M | $547.5K |
| Sep 2019 | $7.5M | $-16.6M | $5.0K |
| Dec 2019 | $6.9M | $-20.5M | $18.9K |
| Mar 2020 | $6.1M | $-11.1M | $178 |
| Jun 2020 | $6.2M | $-12.2M | $5.3K |
| Sep 2020 | $6.2M | $-12.8M | $2.6K |
| Dec 2020 | $6.8M | $-14.4M | $13.4K |
| Mar 2021 | $6.8M | $-16.0M | $86.0K |
| Jun 2021 | $6.7M | $-17.0M | $8.5K |
| Sep 2021 | $6.8M | $-18.2M | $5.7K |
| Dec 2021 | $7.3M | $-15.8M | $85.9K |
| Mar 2022 | $7.4M | $-18.0M | $60.0K |
| Jun 2022 | $7.4M | $-19.2M | — |
| Sep 2022 | $7.3M | $-19.6M | $23.1K |
| Dec 2022 | $7.2M | $-32.2M | $98 |
| Mar 2023 | $6.9M | $-24.4M | $10.9K |
| Jun 2023 | $7.1M | $-22.4M | $32.6K |
| Sep 2023 | $7.1M | $-23.0M | $0 |